The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Featured Deals

All
Industries

Acquisition Deals

Histogenics, Ocugen reverse merge to create public ophthalmic-focused gene therapy development firm
Deal Date: Apr-2019 / Publish Date: Apr-08-2019

Alliance Deals

PhaseBio grants ImmunoForge rights to sarcopenia candidate
Deal Date: Apr-2019 / Publish Date: Apr-11-2019

Gilead becomes insitro's first major partner in deal potentially worth over $1bn
Deal Date: Apr-2019 / Publish Date: Apr-17-2019

BioSense Global to develop and sell Rexahn's RX3117 in Greater China
Deal Date: Apr-2019 / Publish Date: Apr-17-2019

Financing Deals

Homology Medicines nets $117.5mm via FOPO
Deal Date: Apr-2019 / Publish Date: Apr-11-2019

Turning Point nets $178mm in initial public offering
Deal Date: Apr-2019 / Publish Date: Apr-18-2019

Immuno-oncology firm Elicio launches, raises $30mm in first round
Deal Date: Mar-2019 / Publish Date: Apr-15-2019


Acquisition Deals

Smith & Nephew acquires pressure injury prevention and monitoring device firm Leaf Healthcare
Deal Date: Apr-2019 / Publish Date: Apr-02-2019

Alliance Deals

Cerevast, Lantheus sign deal for retinal vein occlusion device
Deal Date: Apr-2019 / Publish Date: Apr-04-2019

Micro Interventional Devices, Oscor team up in structural heart disease
Deal Date: Mar-2019 / Publish Date: Mar-19-2019

Financing Deals

Intrinsic raises $52mm via late-stage financing
Deal Date: Apr-2019 / Publish Date: Apr-15-2019

ABK Biomedical raises $30mm in Series B round
Deal Date: Apr-2019 / Publish Date: Apr-10-2019

Cerus signs debt facility for up to $90mm; $40mm drawn at closing
Deal Date: Apr-2019 / Publish Date: Apr-04-2019

Public offering brings in $24.9mm for PolarityTE
Deal Date: Apr-2019 / Publish Date: Apr-12-2019


In Vitro Diagnostics

Email Alert |   RSS Feed

Alliance Deals

OncoTracker licenses key patents from IMBCR
Deal Date: Mar-2019 / Publish Date: Mar-18-2019

Natera to launch Signatera test in China on BGI's DNBseq NGS platform
Deal Date: Mar-2019 / Publish Date: Mar-12-2019

Financing Deals

Epizyme nets $160.4mm through concurrent offerings of common and preferred shares
Deal Date: Mar-2019 / Publish Date: Mar-09-2019

Exact Sciences nets $634mm through upsized public notes offering
Deal Date: Mar-2019 / Publish Date: Mar-09-2019

Invitae nets $184.9mm in FOPO
Deal Date: Mar-2019 / Publish Date: Mar-08-2019


Acquisition Deals

Ironwood spins off Cyclerion
Deal Date: Apr-2019 / Publish Date: Apr-04-2019

Novartis acquires NLRP3 inflammasome-focused IFM Tre for up to $1.58bn
Deal Date: Apr-2019 / Publish Date: Apr-03-2019

Alliance Deals

Salix gets license to UCLA compound
Deal Date: Apr-2019 / Publish Date: Apr-04-2019

BI, PureTech collaborate on I/O candidates in $226mm tie-up
Deal Date: Apr-2019 / Publish Date: Apr-18-2019

Castle Creek licenses US rights to Fibrocell's FCX007 RDEB gene therapy candidate for up to $135mm
Deal Date: Apr-2019 / Publish Date: Apr-17-2019

Financing Deals

Outlook Therapeutics nets $26.8mm via FOPO
Deal Date: Apr-2019 / Publish Date: Apr-15-2019

Arteaus sells Emgality royalties to Royalty Pharma in $260mm financing
Deal Date: Apr-2019 / Publish Date: Apr-08-2019

X4 Pharmaceuticals nets $80.2mm through public offering
Deal Date: Apr-2019 / Publish Date: Apr-16-2019

Biotechnology

Acquisition Deals

Histogenics, Ocugen reverse merge to create public ophthalmic-focused gene therapy development firm
Deal Date: Apr-2019 / Publish Date: Apr-08-2019

Alliance Deals

PhaseBio grants ImmunoForge rights to sarcopenia candidate
Deal Date: Apr-2019 / Publish Date: Apr-11-2019

Gilead becomes insitro's first major partner in deal potentially worth over $1bn
Deal Date: Apr-2019 / Publish Date: Apr-17-2019

BioSense Global to develop and sell Rexahn's RX3117 in Greater China
Deal Date: Apr-2019 / Publish Date: Apr-17-2019

Financing Deals

Homology Medicines nets $117.5mm via FOPO
Deal Date: Apr-2019 / Publish Date: Apr-11-2019

Turning Point nets $178mm in initial public offering
Deal Date: Apr-2019 / Publish Date: Apr-18-2019

Immuno-oncology firm Elicio launches, raises $30mm in first round
Deal Date: Mar-2019 / Publish Date: Apr-15-2019

Medical
Devices

Acquisition Deals

Smith & Nephew acquires pressure injury prevention and monitoring device firm Leaf Healthcare
Deal Date: Apr-2019 / Publish Date: Apr-02-2019

Alliance Deals

Cerevast, Lantheus sign deal for retinal vein occlusion device
Deal Date: Apr-2019 / Publish Date: Apr-04-2019

Micro Interventional Devices, Oscor team up in structural heart disease
Deal Date: Mar-2019 / Publish Date: Mar-19-2019

Financing Deals

Intrinsic raises $52mm via late-stage financing
Deal Date: Apr-2019 / Publish Date: Apr-15-2019

ABK Biomedical raises $30mm in Series B round
Deal Date: Apr-2019 / Publish Date: Apr-10-2019

Cerus signs debt facility for up to $90mm; $40mm drawn at closing
Deal Date: Apr-2019 / Publish Date: Apr-04-2019

Public offering brings in $24.9mm for PolarityTE
Deal Date: Apr-2019 / Publish Date: Apr-12-2019

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert |   RSS Feed

Alliance Deals

OncoTracker licenses key patents from IMBCR
Deal Date: Mar-2019 / Publish Date: Mar-18-2019

Natera to launch Signatera test in China on BGI's DNBseq NGS platform
Deal Date: Mar-2019 / Publish Date: Mar-12-2019

Financing Deals

Epizyme nets $160.4mm through concurrent offerings of common and preferred shares
Deal Date: Mar-2019 / Publish Date: Mar-09-2019

Exact Sciences nets $634mm through upsized public notes offering
Deal Date: Mar-2019 / Publish Date: Mar-09-2019

Invitae nets $184.9mm in FOPO
Deal Date: Mar-2019 / Publish Date: Mar-08-2019

Pharmaceuticals

Acquisition Deals

Ironwood spins off Cyclerion
Deal Date: Apr-2019 / Publish Date: Apr-04-2019

Novartis acquires NLRP3 inflammasome-focused IFM Tre for up to $1.58bn
Deal Date: Apr-2019 / Publish Date: Apr-03-2019

Alliance Deals

Salix gets license to UCLA compound
Deal Date: Apr-2019 / Publish Date: Apr-04-2019

BI, PureTech collaborate on I/O candidates in $226mm tie-up
Deal Date: Apr-2019 / Publish Date: Apr-18-2019

Castle Creek licenses US rights to Fibrocell's FCX007 RDEB gene therapy candidate for up to $135mm
Deal Date: Apr-2019 / Publish Date: Apr-17-2019

Financing Deals

Outlook Therapeutics nets $26.8mm via FOPO
Deal Date: Apr-2019 / Publish Date: Apr-15-2019

Arteaus sells Emgality royalties to Royalty Pharma in $260mm financing
Deal Date: Apr-2019 / Publish Date: Apr-08-2019

X4 Pharmaceuticals nets $80.2mm through public offering
Deal Date: Apr-2019 / Publish Date: Apr-16-2019

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel